Erythropoietic protein supportive treatment in small cell lung cancer

Magyar onkologia
Lilla TamásiGyörgy Losonczy

Abstract

Anemia is common among patients with malignant tumors, due to the disease and chemotherapy. Anemia decreases patient's quality of life, and worsens the dose intensity of chemotherapy. The aim of this retrospective data-analysis was to determine the rate of transfusions and the maintenance of chemotherapeutic dose intensity in 9 small cell lung cancer patients receiving beta-erythropoietin, due to anemia observed after the first cycle of chemotherapy. The mean pre-treatment hemoglobin concentration of the patients was 116.67+/-8.17 g/L (mean+/-SD). The mean pre-erythropoietin hemoglobin concentration at baseline was 103.11+/-7.52 g/L. Six cycles of platinum compounds and etoposide were used. The post-treatment hemoglobin concentration of patients was 110.11+/-5.37 g/L (p = 0,028 vs. baseline). During these 54 chemotherapeutic cycles, only 2 patients needed transfusion, each of them once. According to our experience, the use of beta-erythropoietin in 9 anemic small cell lung cancer patients resulted in a low rate of transfusions and maintenance of cytotoxic treatment dose intensity. The adequate use of beta-erythropoietin is of great help to the physician in the management of small cell lung cancer patients.

References

Jun 14, 1990·The New England Journal of Medicine·C B MillerJ L Spivak
Sep 30, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Heinz LudwigDirk Schrijvers
Oct 4, 2005·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Jan Foubert
Dec 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas GroteDaniel J Sullivan
May 18, 2006·Journal of the National Cancer Institute·Julia BohliusAndreas Engert
Jul 20, 2006·Expert Opinion on Therapeutic Targets·Rachida S Bel AibaThomas Kietzmann
Aug 16, 2006·Neuro-degenerative Diseases·E A DunlopT R Lappin
Nov 7, 2006·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Robert PirkerWilma Minar
Dec 22, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C BokemeyerUNKNOWN European Organisation for Research and Treatment of Cancer (EORTC) Taskforce for the Elderly

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.